Case Report June 11, 2024

Psychosis With Use of an Herbal Chinese Slimming Product

; ; ; ;

Prim Care Companion CNS Disord 2024;26(3):23cr03590

  1. Chen SPL, Tang MHY, Ng SW, et al. Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series. Clin Toxicol (Phila). 2010;48(8):832–838. PubMed CrossRef
  2. US Food and Drug Administration. Public notification: queen slimming soft gel contains hidden drug ingredient. Accessed June 21, 2023. https://www.fda.gov/drugs/medication-health-fraud/publicnotification-queen-slimming-soft-gel-containshidden-drug-ingredient
  3. Chong CSY. Psychosis related to the use of sibutramine disguised as over-the-counter herbal weight loss remedies: a report of two patients. East Asian Arch Psychiatry. 2010;20(4):186–189. PubMed
  4. Waszkiewicz N, Zalewska-Szajda B, Szajda SD, et al. Sibutramine-induced mania as the first manifestation of bipolar disorder. BMC Psychiatry. 2012;12:43. PubMed CrossRef
  5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. PubMed CrossRef
  6. Muschietti L, Redko F, Ulloa J. Adulterants in selected dietary supplements and their detection methods. Drug Test Anal. 2020;12(7):861–886. PubMed CrossRef
  7. Hachem R, Assemat G, Martins N, et al. Proton NMR for detection, identification and quantification of adulterants in 160 herbal food supplements marketed for weight loss. J Pharm Biomed Anal. 2016;124:34–47. PubMed CrossRef
  8. Araújo JR, Martel F. Sibutramine effects on central mechanisms regulating energy homeostasis. Curr Neuropharmacol. 2012;10(1):49–52. PubMed
  9. Jo HS, Wang SM, Kim JJ. Recurrent psychosis after phentermine administration in a young female: a case report. Clin Psychopharmacol Neurosci. 2019;17(1):130–133. PubMed CrossRef
  10. van der Zwaal EM, Janhunen SK, Luijendijk MCM, et al. Olanzapine and sibutramine have opposing effects on the motivation for palatable food. Behav Pharmacol. 2012;23(2):198–204. PubMed CrossRef